The future of drug development: the economics of pharmacogenomics
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2005
|
Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11875 |
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | 47 S. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000zcb4500 | ||
---|---|---|---|
001 | BV023591858 | ||
003 | DE-604 | ||
005 | 20090618 | ||
007 | t | ||
008 | 060328s2005 xxud||| |||| 00||| eng d | ||
035 | |a (OCoLC)62869904 | ||
035 | |a (DE-599)BVBBV023591858 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
044 | |a xxu |c XD-US | ||
049 | |a DE-521 |a DE-19 | ||
050 | 0 | |a HB1 | |
100 | 1 | |a Vernon, John A. |e Verfasser |0 (DE-588)130457043 |4 aut | |
245 | 1 | 0 | |a The future of drug development |b the economics of pharmacogenomics |c John A. Vernon ; W. Keener Hughen |
264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2005 | |
300 | |a 47 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11875 | |
650 | 4 | |a Drug Industry |x economics | |
650 | 4 | |a Pharmacogenetics |x economics | |
650 | 4 | |a Pharmacogenomics |x Economic aspects | |
700 | 1 | |a Hughen, W. Keener |d 1966- |e Verfasser |0 (DE-588)131571311 |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11875 |w (DE-604)BV002801238 |9 11875 | |
856 | 4 | 1 | |u http://papers.nber.org/papers/w11875.pdf |z kostenfrei |3 Volltext |
999 | |a oai:aleph.bib-bvb.de:BVB01-016907188 |
Datensatz im Suchindex
_version_ | 1804138249704177664 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Vernon, John A. Hughen, W. Keener 1966- |
author_GND | (DE-588)130457043 (DE-588)131571311 |
author_facet | Vernon, John A. Hughen, W. Keener 1966- |
author_role | aut aut |
author_sort | Vernon, John A. |
author_variant | j a v ja jav w k h wk wkh |
building | Verbundindex |
bvnumber | BV023591858 |
callnumber-first | H - Social Science |
callnumber-label | HB1 |
callnumber-raw | HB1 |
callnumber-search | HB1 |
callnumber-sort | HB 11 |
callnumber-subject | HB - Economic Theory and Demography |
ctrlnum | (OCoLC)62869904 (DE-599)BVBBV023591858 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01389nam a2200361zcb4500</leader><controlfield tag="001">BV023591858</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090618 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060328s2005 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)62869904</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591858</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vernon, John A.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130457043</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The future of drug development</subfield><subfield code="b">the economics of pharmacogenomics</subfield><subfield code="c">John A. Vernon ; W. Keener Hughen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">47 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11875</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenomics</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hughen, W. Keener</subfield><subfield code="d">1966-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)131571311</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11875</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11875</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11875.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016907188</subfield></datafield></record></collection> |
id | DE-604.BV023591858 |
illustrated | Illustrated |
index_date | 2024-07-02T22:41:29Z |
indexdate | 2024-07-09T21:25:11Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016907188 |
oclc_num | 62869904 |
open_access_boolean | 1 |
owner | DE-521 DE-19 DE-BY-UBM |
owner_facet | DE-521 DE-19 DE-BY-UBM |
physical | 47 S. graph. Darst. |
publishDate | 2005 |
publishDateSearch | 2005 |
publishDateSort | 2005 |
publisher | National Bureau of Economic Research |
record_format | marc |
series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
spelling | Vernon, John A. Verfasser (DE-588)130457043 aut The future of drug development the economics of pharmacogenomics John A. Vernon ; W. Keener Hughen Cambridge, Mass. National Bureau of Economic Research 2005 47 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11875 Drug Industry economics Pharmacogenetics economics Pharmacogenomics Economic aspects Hughen, W. Keener 1966- Verfasser (DE-588)131571311 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11875 (DE-604)BV002801238 11875 http://papers.nber.org/papers/w11875.pdf kostenfrei Volltext |
spellingShingle | Vernon, John A. Hughen, W. Keener 1966- The future of drug development the economics of pharmacogenomics National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Drug Industry economics Pharmacogenetics economics Pharmacogenomics Economic aspects |
title | The future of drug development the economics of pharmacogenomics |
title_auth | The future of drug development the economics of pharmacogenomics |
title_exact_search | The future of drug development the economics of pharmacogenomics |
title_exact_search_txtP | The future of drug development the economics of pharmacogenomics |
title_full | The future of drug development the economics of pharmacogenomics John A. Vernon ; W. Keener Hughen |
title_fullStr | The future of drug development the economics of pharmacogenomics John A. Vernon ; W. Keener Hughen |
title_full_unstemmed | The future of drug development the economics of pharmacogenomics John A. Vernon ; W. Keener Hughen |
title_short | The future of drug development |
title_sort | the future of drug development the economics of pharmacogenomics |
title_sub | the economics of pharmacogenomics |
topic | Drug Industry economics Pharmacogenetics economics Pharmacogenomics Economic aspects |
topic_facet | Drug Industry economics Pharmacogenetics economics Pharmacogenomics Economic aspects |
url | http://papers.nber.org/papers/w11875.pdf |
volume_link | (DE-604)BV002801238 |
work_keys_str_mv | AT vernonjohna thefutureofdrugdevelopmenttheeconomicsofpharmacogenomics AT hughenwkeener thefutureofdrugdevelopmenttheeconomicsofpharmacogenomics |